Baupost Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,226,839
| Closed | -$465K | – | 38 |
|
|
2018
Q1 | $465K | Hold |
2,226,839
| – | – | ﹤0.01% | 33 |
|
|
2017
Q4 | $2.87M | Hold |
2,226,839
| – | – | 0.03% | 33 |
|
|
2017
Q3 | $4.72M | Hold |
2,226,839
| – | – | 0.06% | 34 |
|
|
2017
Q2 | $6.46M | Hold |
2,226,839
| – | – | 0.07% | 38 |
|
|
2017
Q1 | $7.66M | Hold |
2,226,839
| – | – | 0.09% | 40 |
|
|
2016
Q4 | $3.88M | Hold |
2,226,839
| – | – | 0.05% | 42 |
|
|
2016
Q3 | $7.39M | Sell |
2,226,839
-1
| -0% | -$4 | 0.11% | 39 |
|
|
2016
Q2 | $9.57M | Hold |
2,226,840
| – | – | 0.13% | 36 |
|
|
2016
Q1 | $12.5M | Buy |
2,226,840
+2,000,000
| +882% | +$26M | 0.18% | 30 |
|
|
2015
Q4 | $3.9M | Buy |
226,840
+144,704
| +176% | +$3.45M | 0.07% | 34 |
|
|
2015
Q3 | $1.53M | Buy |
+82,136
| New | +$2.81M | 0.03% | 41 |
|
